A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.Dermatol Clin. 2018 Apr; 36(2):135-150.DC
Abstract
Papulopustular rosacea is characterized by papules and pustules in the central facial region. We review the literature surrounding the treatment of papulopustular rosacea. PubMed, EMBASE, and Cochrane (Central) databases searches of articles published from 1980 to 2015 were performed using the MeSH terms or keywords "rosacea" and "clinical trial." Additional searches were performed to include rosacea and each treatment modality used. Topical metronidazole, azelaic acid, ivermectin, and oral doxycycline have the most robust data to support their use. Variation in assessment tools and a lack of clinical trial standardization makes comparison of therapeutic options difficult.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
29499797
Citation
McGregor, Sean P., et al. "A Review of the Current Modalities for the Treatment of Papulopustular Rosacea." Dermatologic Clinics, vol. 36, no. 2, 2018, pp. 135-150.
McGregor SP, Alinia H, Snyder A, et al. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatol Clin. 2018;36(2):135-150.
McGregor, S. P., Alinia, H., Snyder, A., Tuchayi, S. M., Fleischer, A., & Feldman, S. R. (2018). A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatologic Clinics, 36(2), 135-150. https://doi.org/10.1016/j.det.2017.11.009
McGregor SP, et al. A Review of the Current Modalities for the Treatment of Papulopustular Rosacea. Dermatol Clin. 2018;36(2):135-150. PubMed PMID: 29499797.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.
AU - McGregor,Sean P,
AU - Alinia,Hossein,
AU - Snyder,Alyson,
AU - Tuchayi,Sara Moradi,
AU - Fleischer,Alan,Jr
AU - Feldman,Steven R,
Y1 - 2017/12/21/
PY - 2018/3/4/entrez
PY - 2018/3/4/pubmed
PY - 2018/9/13/medline
KW - Azelaic acid
KW - Doxycycline
KW - Ivermectin
KW - Management
KW - Metronidazole
KW - Papulopustular
KW - Rosacea
KW - Topical
SP - 135
EP - 150
JF - Dermatologic clinics
JO - Dermatol Clin
VL - 36
IS - 2
N2 - Papulopustular rosacea is characterized by papules and pustules in the central facial region. We review the literature surrounding the treatment of papulopustular rosacea. PubMed, EMBASE, and Cochrane (Central) databases searches of articles published from 1980 to 2015 were performed using the MeSH terms or keywords "rosacea" and "clinical trial." Additional searches were performed to include rosacea and each treatment modality used. Topical metronidazole, azelaic acid, ivermectin, and oral doxycycline have the most robust data to support their use. Variation in assessment tools and a lack of clinical trial standardization makes comparison of therapeutic options difficult.
SN - 1558-0520
UR - https://brain.unboundmedicine.com/medline/citation/29499797/A_Review_of_the_Current_Modalities_for_the_Treatment_of_Papulopustular_Rosacea_
DB - PRIME
DP - Unbound Medicine
ER -